Elevated expression of the anti-apoptotic protein BCL2 is a hallmark of CLL, driving the accumulation of mature leukemic lymphocytes (Hanada et al., 1993). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.